发明名称 MEDICINE COMPRISING 2-FURANCARBOXYLIC ACID HYDRAZIDE COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide a medicine having strong glucagon receptor antagonism and useful as a preventing and/or treating agent for symptoms and disease to which glucagon relates. SOLUTION: The medicament comprises a 2-furancarboxylic acid hydrazide compound expressed by formula (I) [A is a group or the like expressed by formula (a) (wherein, one of R<SP>4</SP>and R<SP>5</SP>is cyano, nitro or the like, and the other is H or the like) or the like; one of R<SP>1</SP>and R<SP>2</SP>is a group: -D-(X)<SB>m</SB>-R<SP>6</SP>(D is an aryl; X is O or the like; R<SP>6</SP>is an alkyl, an aryl, an arylalkyl or the like; and m is 0 or 1) or the like, and the other is a group: -E-(Y)<SB>n</SB>-R<SP>7</SP>(E is an aryl; Y is O or the like; R<SP>7</SP>is an alkyl, an aryl, an arylalkyl or the like; and n is 0 or 1), H, an aryl or the like; and R<SP>3</SP>is H or the like; provided that, the aryl may be substituted], its prodrug, its physiologically acceptable salt, its hyrdate, or its solvate. COPYRIGHT: (C)2005,JPO&NCIPI
申请公布号 JP2005060385(A) 申请公布日期 2005.03.10
申请号 JP20040221165 申请日期 2004.07.29
申请人 DAINIPPON PHARMACEUT CO LTD 发明人 FUJII AKIHITO;NEGORO TOSHIYUKI;MIGIHASHI CHIAKI;MURATA MAKOTO;NAKAMURA KEIJI;ONDA TAKASHI;MATSUMOTO TAKASHI;KONNO KIYOMI
分类号 C07D307/68;A61K31/341;A61K31/381;A61K31/40;A61K31/404;A61K31/443;A61K31/4525;A61K31/455;A61K31/4709;A61P1/00;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P43/00;C07D405/04;C07D405/12;C07D409/04;C07D409/12;(IPC1-7):A61K31/341;A61K31/452;A61K31/470 主分类号 C07D307/68
代理机构 代理人
主权项
地址